Pansoral Gel

Introduction

Pansoral is a topical medication that contains two active ingredients: Choline Salicylate and Cetalkonium Chloride. It is commonly used to relieve pain and inflammation associated with various oral conditions, such as mouth ulcers, sore gums, and denture irritation.

Uses

Pansoral is prescribed to treat a range of oral conditions. It provides effective relief from pain, inflammation, and discomfort caused by mouth ulcers, gum irritation, and denture sores. This medication can help alleviate symptoms and promote healing, allowing individuals to carry out their daily activities with greater comfort.

Dosage and Administration

follow the instructions provided by your healthcare professional or the information on the product label. For adults and children above 16 years of age, a small amount of Pansoral should be applied directly to the affected area using a clean finger or a cotton swab. The gel should be gently massaged into the affected area until it is evenly distributed. It is advisable to apply the gel up to four times a day, or as directed by your healthcare professional.

Mechanism of Action

Pansoral contains Choline Salicylate, which belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It works by reducing the production of certain chemicals in the body that cause pain and inflammation. Additionally, Cetalkonium Chloride, an antiseptic agent, helps prevent infection and promotes healing of the affected area.

Side Effects

Common side effects may include a temporary stinging or burning sensation at the site of application. If these side effects persist or worsen, it is advisable to consult your healthcare professional.

Serious side effects are rare, but if you experience any signs of an allergic reaction, such as severe rash, swelling, or difficulty breathing, seek immediate medical attention.

Drug Interactions

Before using Pansoral, inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. There are currently no known significant drug interactions associated with Pansoral. However, it is always prudent to consult with your healthcare professional to ensure the safe and effective use of this medication.

Precautions

• Pansoral is for external use only and should not be swallowed. Avoid contact with the eyes and other mucous membranes.
• Inform your healthcare professional if you have a known allergy to salicylates or any other ingredients in the gel.
• This medication should not be used in children under the age of 16 without the advice of a healthcare professional.
• If symptoms persist or worsen after using Pansoral, or if new symptoms develop, consult your healthcare professional.

Storage

Patient Tips

• Do not apply Pansoral to open wounds or broken skin.
• Avoid eating or drinking immediately after applying the gel to allow it to fully take effect.
• Maintain good oral hygiene practices, such as regular brushing and flossing, to support the healing process.
• If you accidentally swallow the gel or experience any signs of overdose, seek medical attention immediately.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Vitamins and minerals – Others (NHS UK) [Accessed 15 Jun. 2024] (online) Available at:
• Bonjela (Health Professionals SmPC) Available at:
• Generic Verkazia Availability (Drugs.com) [Accessed 16 Jun. 2024] (online) Available at:
• eltrombopag choline 54 mg tablet (RX) [Accessed 12 Jun. 2024] (online) Available at:
• LactMed: Drugs and Lactation Database (National Library of Medicine) [Accessed 1 Jun. 2024] (online) Available at:
• Daull P, Lallemand F, Garrigue JS. Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. J Pharm Pharmacol. 2014 Apr;66(4):531-41. doi: 10.1111/jphp.12075. [Accessed 30 Jun. 2024] Available at: